Home/Filings/4/0001415889-25-011118
4//SEC Filing

Larson Jeffrey Leroy 4

Accession 0001415889-25-011118

CIK 0001346830other

Filed

Apr 20, 8:00 PM ET

Accepted

Apr 21, 5:15 PM ET

Size

5.8 KB

Accession

0001415889-25-011118

Insider Transaction Report

Form 4
Period: 2025-04-17
Larson Jeffrey Leroy
SVP, Research & Development
Transactions
  • Award

    Employee Stock Option (right to buy)

    2025-04-17+10,82010,820 total
    Exercise: $17.04Exp: 2035-04-16Common Stock (10,820 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the option shall vest on April 17, 2026, and the balance of the shares subject to the option shall vest in equal monthly installments over the following 36 months, subject to the Reporting Person's continuous service through each applicable vesting date.

Issuer

Tvardi Therapeutics, Inc.

CIK 0001346830

Entity typeother

Related Parties

1
  • filerCIK 0002064985

Filing Metadata

Form type
4
Filed
Apr 20, 8:00 PM ET
Accepted
Apr 21, 5:15 PM ET
Size
5.8 KB